Literature DB >> 11477736

Pulmonary involvement in a child with ligneous conjunctivitis and homozygous type I plasminogen deficiency.

U Ozçelik1, Z Akçören, D Anadol, N Kiper, M Orhon, A Göçmen, M Irkeç, V Schuster.   

Abstract

Ligneous conjunctivitis (LC) is a rare disorder characterized by a chronic course of recurrent membranous lesions at conjunctivae. Pseudomembranes of other mucous membranes have been reported in patients with LC, but to the best of our knowledge, no case with alveolar involvement has been described. Here, we report a 2.5-year-old girl with LC who had tracheoaveolar involvement and homozygous type I plasminogen deficiency. Tracheal involvement was diagnosed by bronchoscopic biopsy and alveolar involvement with postmortem biopsy. She was shown to be homozygous for frameshift mutation in plasminogen exon 14 (Gly565ins-G) with molecular genetic examination of DNA which was obtained from parafin embedded postmortem lung tissue. Ligneous inflammation of the upper and lower respiratory tract must be considered in children with LC and recurrent respiratory tract problems. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477736     DOI: 10.1002/ppul.1105

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  3 in total

1.  Ligneous conjunctivitis: a clinicopathological, immunohistochemical, and genetic study including the treatment of two sisters with multiorgan involvement.

Authors:  M Teresa Rodríguez-Ares; Ihab Abdulkader; Ana Blanco; Rosario Touriño-Peralba; Clara Ruiz-Ponte; Ana Vega; José Cameselle-Teijeiro
Journal:  Virchows Arch       Date:  2007-08-15       Impact factor: 4.064

2.  Ligneous conjunctivitis, hydrocephalus, hydrocele, and pulmonary involvement in a child with homozygous type I plasminogen deficiency.

Authors:  Ergin Çiftçi; Erdal Ince; Nejat Akar; Ülker Dogru; Katrin Tefs; Volker Schuster
Journal:  Eur J Pediatr       Date:  2003-04-26       Impact factor: 3.183

Review 3.  Plasminogen deficiency.

Authors:  Tiraje Celkan
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.